Edition:
United States

Neurosearch A/S (NEUR.CO)

NEUR.CO on Copenhagen Stock Exchange

4.05DKK
23 May 2018
Change (% chg)

kr.-0.15 (-3.57%)
Prev Close
kr.4.20
Open
kr.4.10
Day's High
kr.4.13
Day's Low
kr.3.95
Volume
265,533
Avg. Vol
82,747
52-wk High
kr.5.20
52-wk Low
kr.2.80

Latest Key Developments (Source: Significant Developments)

RegNeurosearch And Teva Pharmaceutical International Enter Into Agreement On Outstanding Obligations
Wednesday, 16 May 2018 01:22pm EDT 

May 16 (Reuters) - Neurosearch A/S ::REG-NEUROSEARCH AND TEVA PHARMACEUTICAL INTERNATIONAL ENTER INTO AGREEMENT ON OUTSTANDING OBLIGATIONS.AGREEMENT TO RELEASE TEVA FROM OUTSTANDING OBLIGATIONS PURSUANT TO 2012 AGREEMENT CONCERNING TRANSFER OF CO'S RIGHTS IN AND TO PRIDOPIDINE.PROVIDED AGREEMENT IS COMPLETED,CO'S FINANCIAL EXPECTATIONS FOR 2018 WILL BE AMENDED FROM LOSS OF DKK 3.5-4.5 MILLION TO LOSS OF DKK 0.8-1.8 MILLION.  Full Article

Neurosearch: Gefion To Launch A Takeover Offer On Neurosearch
Friday, 27 Apr 2018 03:55am EDT 

April 27 (Reuters) - Neurosearch A/S ::REG-DECISION ON LAUNCH OF CONDITIONAL, VOLUNTARY OFFER.RECEIVED A NOTICE FROM GEFION GROUP INVESTMENTS A/S THAT GEFION DECIDED TO LAUNCH A CONDITIONAL, VOLUNTARY TAKEOVER OFFER.NEUROSEARCH - GEFION OFFER TO ACQUIRE ENTIRE SHARE CAPITAL OF NEUROSEARCH (EXCLUDING ANY TREASURY SHARES) AGAINST CASH CONSIDERATION OF DKK 4.00 PER SHARE.BOARD WITHDRAWS PROPOSAL FOR ANNUAL GENERAL MEETING TO DECIDE TO LIQUIDATE NEUROSEARCH.RECOMMENDS SHAREHOLDERS TO VOTE AGAINST CONVERSION OF COMPANY INTO AN INVESTMENT COMPANY..BOARD RECOMMENDS NEUROSEARCH'S SHAREHOLDERS TO AWAIT THIS STATEMENT PRIOR TO POTENTIALLY ACCEPTING OFFER.  Full Article

Neurosearch Says Is Investigating Potential Sale Of Company
Thursday, 19 Apr 2018 09:52am EDT 

April 19 (Reuters) - NEUROSEARCH A/S ::SAYS IS IN DISCUSSIONS WITH REGARD TO POTENTIAL SALE OF ITS RIGHTS TO PRIDOPIDINE FOR A SMALL SEVEN FIGURE AMOUNT IN DKK.SAYS IS STILL INVESTIGATING POTENTIAL SALE OF COMPANY.  Full Article

Neurosearch Contemplates Divestiture Of The Company
Tuesday, 5 Dec 2017 02:02am EST 

Dec 5 (Reuters) - NEUROSEARCH A/S ::UPDATE ON NEUROSEARCH’S BUSINESS STATUS AND FUTURE.‍IS NOW AT A STAGE OF ITS RESOLUTION PLAN AT WHICH IT INTENDS TO EXPLORE POSSIBILITY OF DIVESTING COMPANY DURING COMING MONTHS​.‍IN 2017, NEUROSEARCH EXPECTS AN OPERATING LOSS OF APPROXIMATELY DKK 1 MILLION​.  Full Article

NeuroSearch upgrades its guidance for 2017
Friday, 17 Nov 2017 02:00am EST 

Nov 17 (Reuters) - NEUROSEARCH A/S ::NEUROSEARCH UPGRADES ITS GUIDANCE FOR 2017 <<>>.‍UPGRADES 2017 GUIDANCE FROM AN OPERATING LOSS OF DKK 2.3-3.3 MILLION TO AN OPERATION LOSS OF ABOUT DKK 1 MILLION​.  Full Article

Neurosearch H1 operating loss narrows to DKK 1.4 million
Wednesday, 31 Aug 2016 02:37am EDT 

Neurosearch A/S : H1 operating loss 1.4 million Danish crowns versus loss 3.0 million crowns year ago . H1 loss after tax of continuing operations 1.7 million crowns versus loss of 3.0 million crowns year ago .In 2016 expects operating loss in range of 4 million - 6 million crowns.  Full Article

BRIEF-RegNeurosearch And Teva Pharmaceutical International Enter Into Agreement On Outstanding Obligations

* REG-NEUROSEARCH AND TEVA PHARMACEUTICAL INTERNATIONAL ENTER INTO AGREEMENT ON OUTSTANDING OBLIGATIONS

No consensus analysis data available.